Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy

American Journal of Physiology - Cell Physiology

Volumn 277, Issue 2 46-2, 1999, Pages

  Nakaura, Hiroyuki ^a,b   Morimoto, Sachio ^a   Yanaga, Fumi ^a   Nakata, Masashi ^c   Nishi, Hirofumi ^b   Imaizumi, Tsutomu ^b   Ohtsuki, Iwao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KURUME UNIVERSITY   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcium sensitivity; Cooperativity; Skinned fiber; Truncated mutant

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; TROPONIN I; TROPONIN T;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE MUTATION; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INTRON; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0032864309     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1999.277.2.c225     Document Type: Article

References (10)

1. Anan, R., G. Greve, L. Thierfelder, H. Watkins, W. J. McKenna, S. Solomon, C. Vecchio, H. Shono, S. Nakao, and H. Tanaka. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93: 280-285, 1994.
2. Anderson, P. A., N. N. Malouf, A. E. Oakeley, E. D. Pagani, and P. D. Allen. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ. Res. 69: 1226-1233, 1991.
3. Bonne, G., L. Carrier, J. Bercovici, C. Cruaud, P. Richard, B. Hainque, M. Gautel, S. Labeit, M. James, and J. Beckmann. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophie cardiomyopathy. Not. Genet. 11: 438-440, 1995.
4. Bottinelli, R., D. A. Coviello, C. S. Redwood, M. A. Pellegrino, B. J. Maron, P. Spirito, H. Watkins, and C. Reggiani. A mutant tropomyosin that causes hypertrophie cardiomyopathy is expressed in vivo and associated with an increased calcium sensitivity. Circ. Res. 82: 106-115, 1998.
5. Cuda, G., L. Fananapazir, W. S. Zhu, J. R. Sellers, and N. D. Epstein. Skeletal muscle expression and abnormal function of β-myosin in hypertrophie cardiomyopathy. J. Clin. Invest. 91: 2861-2865, 1993.
6. Epstein, N. D., G. M. Cohn, F. Cyran, and L. Fananapazir. Differences in clinical expression of hypertrophie cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu→Val mutation and a 403Arg→Gin mutation. Circulation 86: 345-352, 1992.
7. Fujita, H., S. Sugiura, S. Momomura, M. Omata, H. Sugi, and K. Sutoh. Characterization of mutant myosins of Dictyostelium discoideum equivalent to human familial hypertrophic cardiomyopathy mutants. Molecular force level of mutant myosins may have a prognostic implication. J. Clin. Invest. 99: 1010-1015, 1997.
8. Geisterfer-Lowrance, A. A., S. Kass, G. Tanigawa, H. P. Vosberg, W. McKenna, C. E. Seidman, and J. G. Seidman. A molecular basis for familial hypertrophie cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 62: 999-1006, 1990.
9. Hatakenaka, M., and I. Ohtsuki. Replacement of three troponin components with cardiac troponin components within single glycerinated skeletal muscle fibers. Biochem. Biophys. Res. Commun. 181: 1022-1027, 1991.
10. 2+-activated tension development of single glycerinated rabbit skeletal muscle fibers. Eur. J. Biochem. 205: 985-993, 1992.